Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

THE JULES BORDET INSTITUTE PROGRAM FOR MOLECULAR PROFILING OF METASTATIC LESIONS: FEASIBILITY. PRECISION - Feasibility.

NCT01932489 is registered in ClinicalTrials.gov with Jules Bordet Institute as lead sponsor.

NCT NCT01932489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01932489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
THE JULES BORDET INSTITUTE PROGRAM FOR MOLECULAR PROFILING OF METASTATIC LESIONS: FEASIBILITY. PRECISION - Feasibility.
Lead sponsor
Jules Bordet Institute
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2013
Completion date
October 31, 2014
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer metastatic, metastatic melanoma, metastatic non-small cell lung carcinoma